NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,013 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $645,000 | +7.0% | 7,369 | 0.0% | 0.12% | -15.8% |
| Q3 2021 | $603,000 | +37.7% | 7,369 | +53.6% | 0.15% | +17.7% |
| Q2 2021 | $438,000 | +6.8% | 4,797 | 0.0% | 0.12% | -3.1% |
| Q1 2021 | $410,000 | -9.5% | 4,797 | 0.0% | 0.13% | -5.9% |
| Q4 2020 | $453,000 | -19.8% | 4,797 | -26.2% | 0.14% | -57.0% |
| Q3 2020 | $565,000 | -0.4% | 6,497 | 0.0% | 0.32% | -7.3% |
| Q2 2020 | $567,000 | +4.6% | 6,497 | -1.2% | 0.34% | -4.2% |
| Q1 2020 | $542,000 | -10.9% | 6,577 | +2.5% | 0.36% | +45.9% |
| Q4 2019 | $608,000 | +9.0% | 6,417 | 0.0% | 0.24% | +1.2% |
| Q3 2019 | $558,000 | -4.8% | 6,417 | 0.0% | 0.24% | -24.0% |
| Q2 2019 | $586,000 | -5.0% | 6,417 | 0.0% | 0.32% | +1.3% |
| Q1 2019 | $617,000 | +12.0% | 6,417 | 0.0% | 0.31% | +0.6% |
| Q4 2018 | $551,000 | +6.4% | 6,417 | +6.8% | 0.31% | +25.9% |
| Q3 2018 | $518,000 | +14.1% | 6,009 | 0.0% | 0.25% | +9.3% |
| Q2 2018 | $454,000 | -10.6% | 6,009 | -0.4% | 0.23% | 0.0% |
| Q1 2018 | $508,000 | -10.4% | 6,032 | -10.7% | 0.23% | -11.7% |
| Q4 2017 | $567,000 | – | 6,756 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
| MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
| SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
| SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
| SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
| First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
| PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
| GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
| Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
| WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |